CAH Cardinal Health Inc.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Recent Analyst Ratings for Cardinal Health Inc.

Date	Price Target	Rating	Analyst
6/3/2025	$179.00	Equal Weight → Overweight	Wells Fargo
2/5/2025	$140.00 → $150.00	Hold → Buy	Jefferies
1/8/2025	$130.00 → $144.00	Hold → Buy	TD Cowen
1/7/2025	$140.00	In-line → Outperform	Evercore ISI
1/6/2025	$132.00 → $145.00	Neutral → Buy	BofA Securities
12/13/2024	$101.00 → $127.00	Underweight → Equal Weight	Wells Fargo
12/4/2024	$139.00	Outperform	Mizuho
2/26/2024	$125.00	Outperform	Leerink Partners
2/9/2024		Hold → Buy	Argus
1/3/2024	$117.00	Overweight	Barclays

See more ratings

Cardinal Health Inc.

Peers

Recent Analyst Ratings for Cardinal Health Inc.

Cardinal Health Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Ramakrishna Sudhakar was granted 1,049 shares (SEC Form 4)

Director Musslewhite Robert W was granted 1,049 shares (SEC Form 4)

New insider Ramakrishna Sudhakar claimed no ownership of stock in the company (SEC Form 3)

New insider Musslewhite Robert W claimed no ownership of stock in the company (SEC Form 3)

Chief Financial Officer Alt Aaron E covered exercise/tax liability with 1,919 shares, decreasing direct ownership by 5% to 34,948 units (SEC Form 4)

Chief Information Officer Greene Michelle D. covered exercise/tax liability with 636 shares, decreasing direct ownership by 3% to 18,606 units (SEC Form 4)

CEO, PSS Segment Weitzman Deborah covered exercise/tax liability with 632 shares, decreasing direct ownership by 1% to 49,129 units (SEC Form 4)

Chief Legal/Compliance Officer Mayer Jessica L covered exercise/tax liability with 676 shares, decreasing direct ownership by 1% to 60,286 units (SEC Form 4)

Chief Accounting Officer Scherer Mary C. covered exercise/tax liability with 90 shares, decreasing direct ownership by 1% to 8,662 units (SEC Form 4)

Chief Human Resources Officer Snow Ola M covered exercise/tax liability with 355 shares, decreasing direct ownership by 1% to 27,161 units (SEC Form 4)